Always Remember - Buy The Dip

Sentiment Analysis For XENT

The news is currently generally neutral for XENT.

Based on TextBlob analysis of Yahoo! Finance news summaries for XENT on 2015-03-03.

Yahoo! Finance News for XENT

Will athenahealth (ATHN) Disappoint Earnings this Season? - Analyst Blog
athenahealth Inc. ( ATHN ) is scheduled to release fourth quarter and full year 2014 results after the closing bell on Feb 5. In the last reported quarter, athenahealth's earnings beat the Zacks Consensus Estimate by a penny, recording

Why Earnings Season Could Be Great for Intersect (XENT) - Tale of the Tape
Investors are always looking for stocks that are poised to beat at earnings season and Intersect ENT, Inc. ( XENT ) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up

Can St. Jude Medical (STJ) Keep Earnings Streak Alive? - Analyst Blog
Global medical devices company, St. Jude Medical, Inc. ( STJ ), is scheduled to report fourth quarter and full year 2014 financial numbers on Jan 28, before the opening bell. Last quarter, the company reported earnings of 97 cents

Will PerkinElmer's (PKI) Earnings Disappoint This Season? - Analyst Blog
PerkinElmer Inc. ( PKI ) is slated to announce fourth quarter and full year 2014 results on Jan 29, 2015. Note that the company has posted an average positive earnings surprise of 2.8% over the last four quarters. Let's

Varian Medical (VAR): Will Earnings Disappoint in Q1? - Analyst Blog
Varian Medical Systems Inc. ( VAR ) is set to report first quarter 2015 results on Jan 28. Last quarter, Varian reported earnings of $1.11 per share, which missed the Zacks Consensus Estimate by a dime. Let's see how

Can CR Bard (BCR) Keep the Earnings Streak Alive in Q4? - Analyst Blog
We expect CR Bard Inc. ( BCR ) to beat earnings when the company reports its fourth quarter and full year 2014 financial numbers on Jan 29, 2015. Last quarter, the company's earnings had surpassed the Zacks Consensus Estimate

Will Accuray (ARAY) Disappoint Earnings Estimates in Q2? - Analyst Blog
Accuray Inc. ( ARAY ) is set to report second quarter 2015 results on Jan 27. Last quarter, the company posted loss of 28 cents per share, which was significantly wider than the Zacks Consensus Estimate of a loss

Will Stryker (SYK) Disappoint this Earnings Season? - Analyst Blog
Stryker Corp ( SYK ) is set to report fourth quarter 2015 results on Jan 27. Last quarter, the company reported earnings of $1.15 per share, which beat the Zacks Consensus Estimate by a penny. Let's see how things

Will Waters (WAT) Surprise Q4 Earnings on Innovations? - Analyst Blog
Waters Corporation ( WAT ) is scheduled to report fourth quarter 2014 results before the opening bell on Jan 27, 2015. Over the last four trailing quarters, the company reported a negative average earnings surprise of 0.72%. However, in

Natus Medical's a Strong Buy on Expanding Product Portfolio - Analyst Blog
On Jan 22, 2015, Zacks Investment Research raised Natus Medical Inc. ( BABY ) to a Zacks Rank #1 (Strong Buy). The bullish view reflects new product launches, strong revenue growth across all businesses and continuing margin expansion.Why the

Intersect ENT (XENT) Shares March Higher, Can It Continue? - Tale of the Tape
As of late, it has definitely been a great time to be an investor in Intersect ENT Inc ( XENT ) . The stock has moved higher by 15.6% in the past month, while it is also above its

Sinus balloons for sale: Entellus Medical sets terms for $70 million IPO
Entellus Medical, which sells a minimally invasive treatment to open obstructed sinus pathways, announced terms for its IPO on Thursday. The Plymouth, MN based company plans to raise $70 million by offering 4.4 million shares at a price range

Intersect ENT (XENT) Worth Watching: Stock Soars 22.3% - Tale of the Tape
Intersect ENT, Inc. ( XENT ) was a big mover last session with its shares surging over 22% on the day. The upside was owing to the company's optimistic announcement of its preliminary revenue results for fourth quarter and

Earnings Reported After The Bell On Jan. 12
Earnings Reported After The Bell On Jan. 12

Intersect ENT Sees Q4 Revenues Above Street
Intersect ENT Sees Q4 Revenues Above Street

Will Intersect ENT (XENT) Continue to Surge Higher? - Tale of the Tape
As of late, it has definitely been a great time to be an investor in Intersect ENT Inc ( XENT ) . The stock has moved higher by 9% in the past month, while it is also above its

Can the Rally in Intersect ENT (XENT) Shares Continue? - Tale of the Tape
Intersect ENT, Inc. ( XENT ) has been on the move lately as the stock has risen by 20.2% in the past four weeks, and it is currently trading well above its 20 Day SMA. This is a pretty